Skip to content

Effect of Personalized Nutritional Education via Generative Artificial Intelligence on Nutritional Status and Quality of Life in Post-Gastrectomy Gastric Cancer Patients: A Randomized Controlled Trial

Effect of Personalized Nutritional Education via Generative Artificial Intelligence on Nutritional Status and Quality of Life in Post-Gastrectomy Gastric Cancer Patients: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123798
Enrollment
Unknown
Registered
2026-04-29
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Intervention group:In addition to routine nutrition education, patient data are collected at postoperative day 7 (baseline), at discharge (approximately 2 weeks postoperatively), and at each return vi
Control group:Routine postoperative nutrition education, including bedside one-on-one guidance and printed educational materials, delivered once during hospitalization only, with no structured follow-

Sponsors

The Second Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed primary gastric cancer; 2. Age >=18 years; 3. Underwent total or subtotal gastrectomy; 4. Stable postoperative vital signs, conscious, and able to take oral food; 5. Basic communication skills and ability to use smartphone for reading and writing in Chinese; 6. Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment, such as dementia; 2. Postoperative gastroparesis, intestinal obstruction, or anastomotic leakage; 3. Participation in other nutritional intervention studies within the past 3 months; 4. Failure to complete the expected duration of the intervention plan; 5. Severe comorbidities, such as end-stage cardiovascular or respiratory diseases; 6. Second primary malignancy (unless curatively treated >5 years ago); 7. Visual, hearing, or speech impairment.

Design outcomes

Primary

MeasureTime frame
Nutritional status;Body Mass Index (BMI);Serum albumin;Serum prealbumin;

Secondary

MeasureTime frame
Quality of Life (QoL);Gastrointestinal Symptoms;

Countries

China

Contacts

Public ContactZhang Miao

The Second Hospital of Anhui Medical University

825615048@qq.com+86 138 6597 5539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026